Vanguard Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for CytomX Therapeutics Inc Common Stock (CTMX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: CytomX Therapeutics Inc Common Stock
Symbol: CTMX
Shares outstanding: 158M shares
Disclosed Ownership: 9.38M shares
Ownership: 5.95%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 11:22 AM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.95%	9.38M	0	0	Ashley Grim	Head of Global Fund Administration